We see that you have javascript disabled. Please enable javascript and refresh the page to continue reading local news. If you feel you have received this message in error, please contact the customer support team at 1-833-248-7801.

ADVERTISEMENT

ADVERTISEMENT

New Mayo Clinic biomanufacturing lab is first announced Two Discovery Square tenant

Mayo Clinic recently announced that it will lease "a minimum of 8,000 square feet" in the recently completed Two Discovery Square building to house a biologic manufacturing operation that is a collaboration between Mayo Clinic’s Center for Regenerative Medicine and biomanufacturer National Resilience Inc.

20220816_115539.jpg
Mayo Clinic recently announced that it will lease "a minimum of 8,000 square feet of space in" the recently completed Two Discovery Square building to house biologic manufacturing operation that is a collaboration between Mayo Clinic’s Center for Regenerative Medicine and biomanufacturer National Resilience Inc.
Jeff Kiger / Post Bulletin
We are part of The Trust Project.

ROCHESTER – Mayo Clinic is the first tenant to be announced for the new Two Discovery Square complex as the base for a new manufacturing facility to create “novel biotherapeutics.”

Mayo Clinic recently announced that it will lease space in the recently completed Two Discovery Square building at 300 Second Ave. SW, which is connected to the smaller One Discovery Square facility.

Also Read
Pescara, which is based on the street level of Rochester's DoubleTree by Hilton hotel, announced this week that it will no longer offer breakfast and weekend brunch as of Oct. 1. The restaurant will still serve lunch and dinner.
Rochester’s four Hy-Vee grocery stores will soon offer a “Scan & Go” option that allows customers to scan items with their phone.

“We are currently in the process of space programming in alignment with our anticipated needs. We expect to lease a minimum of 8,000 square feet of space, and we anticipate the space to be on the fourth floor,” wrote Senior Mayo Clinic Communications Specialist Susan Buckles in response to questions about the proposed biomanufacturing project.

Mayo Clinic’s Center for Regenerative Medicine signed a “strategic collaboration” with La Jolla, Calif.-based biomanufacturer, National Resilience Inc. , to create therapies derived from human sources known as biologics — cells, blood, enzymes, tissues, genes or genetically engineered cells — for use in medicines.

National Resilience is a technology development company that will "optimize and streamline" Mayo Clinic's biomanufacturing facilities.

ADVERTISEMENT

“We are seeking to build a community of innovators to explore ideas, develop new products and create thriving biotherapeutic companies," stated Dr. Julie Allickson of Mayo Clinic's Center for Regenerative Medicine in the announcement. "This nexus of entrepreneurs, startups and industry experts will help position Mayo Clinic as an authority in regenerative biotherapeutics."

Buckles added that Mayo Clinic hopes to occupy the space in Two Discovery Square in the latter part of 2023.

Details such as how many Mayo Clinic employees will staff the new site or how many of those will be new jobs have not been finalized.

“We are still developing our workforce planning and anticipate having a firmer sense of staffing in the new space toward the end of this year. There will be new employees located in this space and potentially some employees that will be relocated from other spaces to gain operational efficiencies,” wrote Buckles.

20220816_115633.jpg
Mayo Clinic recently announced that it will lease "a minimum of 8,000 square feet of space in" the recently completed Two Discovery Square building to house biologic manufacturing operation that is a collaboration between Mayo Clinic’s Center for Regenerative Medicine and biomanufacturer National Resilience Inc.
Jeff Kiger / Post Bulletin

This project makes Mayo Clinic the first organization to announce plans to occupy space in the 121,000-square-foot science and technology complex built and owned by developer M.A. Mortenson Co. The five-story building was completed in early 2022.

Mayo Clinic's plans for the new manufacturing site have four stated areas of focus:

  • Process development expertise to advance Mayo Clinic biotherapeutics.
  • Working together to attract biotech companies interested in sponsoring clinical trials at Mayo Clinic for novel regenerative biotherapeutics.
  • Providing cell and gene products needed for biomanufacturing early-stage therapeutics.
  • Analytical testing and quality control required for manufacturing commercial grade biopharmaceuticals.

"Mayo Clinic will advance regenerative technologies from discovery science to early phase clinical trials," stated Mayo Clinic Executive Dean of Research Dr. Gregory Gores in the announcement.

Jeff Kiger tracks business action in Rochester and southeastern Minnesota every day in "Heard on the Street." Send tips to jkiger@postbulletin.com or via Twitter to @whereskiger . You can call him at 507-285-7798.

ADVERTISEMENT

Heard Around Rochester - Jeff Kiger.png

Jeff Kiger writes a daily column, "Heard Around Rochester," in addition to writing articles about local businesses, Mayo Clinic, IBM, Hormel Foods, Crenlo and others. He has worked in Rochester for the Post Bulletin since 1999. Send tips to jkiger@postbulletin.com or via Twitter to @whereskiger . You can call him at 507-285-7798.
What to read next
Columnist Dave Conrad says the sweet spot is finding the right speed and attention to quality.
The library staff asked one person to leave for refusing to remain quiet during the debate.
Proposed active transportation plan is an update to the 2012 bicycle master plan and highlights 10 potential projects for improved pedestrian and bike connections.
Candidates for Rochester council seats on Nov. 8 ballot were asked to provide video responses regarding proposed plans for Silver Lake Park changes.